PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability

被引：0
|
作者：
Yu, Jiaojiao [1 ]
Xiang, Yujin [1 ]
Gao, Yuzhen [1 ]
Hua, Fang [1 ]
Zhang, Xiaowei [1 ]
Li, Pingping [1 ]
Cui, Bing [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0437
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [31] Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer
    Cen, Bo
    Wei, Jie
    Wang, Dingzhi
    Xiong, Ying
    Shay, Jerry W.
    DuBois, Raymond N.
    ONCOGENE, 2021, 40 (41) : 5984 - 5992
  • [32] Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer
    Bo Cen
    Jie Wei
    Dingzhi Wang
    Ying Xiong
    Jerry W. Shay
    Raymond N. DuBois
    Oncogene, 2021, 40 : 5984 - 5992
  • [33] Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance
    Deng, Yalan
    Xia, Xianghou
    Zhao, Yang
    Zhao, Zilong
    Martinez, Consuelo
    Yin, Wenjuan
    Yao, Jun
    Hang, Qinglei
    Wu, Weiche
    Zhang, Jie
    Yu, Yang
    Xia, Weiya
    Yao, Fan
    Zhao, Di
    Sun, Yutong
    Ying, Haoqiang
    Hung, Mien-Chie
    Ma, Li
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [34] Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance
    Yalan Deng
    Xianghou Xia
    Yang Zhao
    Zilong Zhao
    Consuelo Martinez
    Wenjuan Yin
    Jun Yao
    Qinglei Hang
    Weiche Wu
    Jie Zhang
    Yang Yu
    Weiya Xia
    Fan Yao
    Di Zhao
    Yutong Sun
    Haoqiang Ying
    Mien-Chie Hung
    Li Ma
    Nature Communications, 12
  • [35] Protein O-fucosyltransferase 1 promotes PD-L1 stability to drive immune evasion and directs liver cancer to immunotherapy
    Li, Qianyu
    Guo, Wenyun
    Qian, Yifei
    Li, Songling
    Li, Linfeng
    Zhu, Zijun
    Wang, Fan
    Tong, Yu
    Xia, Qiang
    Liu, Yanfeng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
  • [36] Prospective role of PD-1/PD-L1 immune checkpoint inhibitors in GI cancer
    AmeliMojarad, Mandana
    AmeliMojarad, Melika
    Cui, Xiaonan
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 244
  • [37] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [38] Regulation of PD-L1 in breast cancer
    Zerdes, Ioannis
    Tsesmetzis, Nikolaos
    Lovrot, John
    Rolny, Charlotte
    Bergh, Jonas C. S.
    Rassidakis, Georgios
    Foukakis, Theodoros
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [40] PD-L1 testing in breast cancer
    Horii, Rie
    ANNALS OF ONCOLOGY, 2023, 34 : S1361 - S1361
12345